Sort
15,273 grants matching “antimicrobial resistance”
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium
$662,652Theresa A Freeman · Thomas Jefferson University · R01 · FY2021 · AR
Inhalation Therapy Platform for Coronavirus Infection Treatment
$662,579Patrick S. Stayton · University Of Washington · R01 · FY2023 · AI
A Total Infection Control Foley Catheter System
$662,097Shantha Sarangapani · Innovative Chemical/Environmental Tech · R44 · FY2008 · DK
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
$661,676Michael Stephen Trent · University Of Georgia · R01 · FY2024 · AI
Novel medical device for treatment of fungal nail infection
$661,639Jeffrey N Roe · Devicefarm, Inc. · R44 · FY2016 · GM
Synthesis and transport of outer membrane components across the Gram-negative cell envelope
$661,538Michael Stephen Trent · University Of Georgia · R01 · FY2024 · AI
Chicago Prevention and Intervention Epicenter II (CPIE-II)
$661,534Mary Katherine Hayden · Rush University Medical Center · U54 · FY2018 · CK
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
$661,400Ralph R Isberg · Tufts University Boston · R01 · FY2024 · AI
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
$661,400Ralph R Isberg · Tufts University Boston · R01 · FY2023 · AI
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
$661,400Ralph R Isberg · Tufts University Boston · R01 · FY2021 · AI
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
$661,400Ralph R Isberg · Tufts University Boston · R01 · FY2022 · AI
Project 1: Co-stimulation and Regulation of Anti-viral Immunity
$660,826Arlene H Sharpe · Harvard Medical School · P01 · FY2022 · AI
Biochemistry of Bacterial Cell Membranes
$660,072Hiroshi Nikaido · University Of California Berkeley · R01 · FY2008 · AI
Impact of suppressive antimicrobial therapy on the vaginal microbiota and BV
$659,855Raymond Scott McClelland · University Of Washington · R01 · FY2014 · AI
Clinical factors in aminoglycoside-induced ototoxicity
$659,676Peter S Steyger · Creighton University · R01 · FY2023 · DC
Defining the targets of broad intervention antimalarial agents
$659,642Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2014 · AI
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
$659,526James A. Lederer · Brigham And Women'S Hospital · U01 · FY2014 · AI
A Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU
$659,393Emmanuel B Walter · Duke University · N01 · FY2017 · AI
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection
$659,282Roby Paul Bhattacharyya · Broad Institute, Inc. · R01 · FY2021 · AI
Iron and O2 in the Regulation of P. aeruginosa Virulence
$659,058Michael L. Vasil · University Of Colorado Denver · R37 · FY2008 · AI
Antibiotic Drug Discovery
$659,005Toni B. Kline · University Of Washington · U54 · FY2012 · AI
Task 4: The Interventional Agent Development Services Program
$658,780Jon Carl Mirsalis · Sri International · N01 · FY2017 · AI
Anti-viral Mechanisms of Defensins
$658,513Jason G Smith · University Of Washington · R01 · FY2020 · AI
The LiaFSR system and antimicrobial peptide resistance in enterococci
$658,280Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · AI
Lung-Protective Mechanisms of Metformin in TB
$658,272Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · HL